MC-Val-Cit-PAB-rifabutin

MC-Val-Cit-PAB-rifabutin is a agent-linker conjugate for ADC with potent antitumor activity by using rifabutin (an DNA-dependent RNA polymerase inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

Product Specifications

CAS Number

[2055900-34-8]

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/mc-val-cit-pab-rifabutin.html

Purity

95.33

Solubility

DMSO : 20 mg/mL (ultrasonic)

Smiles

O=C1C2=C(C(C)=C(C3=C2C4=NC5(NC4=C(C3=O)N6)CC[N+](CC(C)C)(CC5)CC7=CC=C(C=C7)NC([C@@H](NC([C@@H](NC(CCCCCN8C(C=CC8=O)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)O)O[C@]1(C)O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@H]([C@H](/C=C/C=C(C)\C6=O)C)O.[Cl-]

Molecular Formula

C74H101ClN10O17

Molecular Weight

1438.10

References & Citations

[1]Staben LR, et al. Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates. Nat Chem. 2016 Dec;8 (12) :1112-1119.